Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Calyx Chemicals & Pharmaceuticals Limited
FDA Inspection
•Calyx Chemicals & Pharmaceuticals Limited•March 4, 2016

Calyx Chemicals & Pharmaceuticals Limited – FDA Inspection, Mar 4, 2016

Record Details

This FDA Inspection record concerns Calyx Chemicals & Pharmaceuticals Limited, with an inspection on March 4, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Calyx Chemicals & Pharmaceuticals Limited
Inspection Date
March 4, 2016
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · f179bf14-ab8e-4879-a384-b878e09ae5c0

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
967429
FDA center
Human Drugs
Project area
Drug Quality Assurance

Other FDA inspections of Calyx Chemicals & Pharmaceuticals Limited

4
DateClassificationOfficeProject area
May 17, 2024OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 8, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 27, 2012VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 18, 2009VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Calyx Chemicals & Pharmaceuticals Limited
  • FDA Inspection 1240456 - 2024-05-17
  • FDA Inspection 1110153 - 2019-11-08
  • FDA Inspection 775620 - 2012-03-27
  • FDA Inspection 641001 - 2009-09-18

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Calyx Chemicals & Pharmaceuticals Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.